Ruti Aga and the six-year ban: the fake prescription weighed heavier than the positive test
**Câu trả lời cốt lõi**: Ruti Aga, vận động viên marathon người Ethiopia 32 tuổi, bị Cơ quan Liêm chính Điền kinh (AIU) treo giò sáu năm vì kết quả dương tính với methylprednisolone cộng với hành vi làm giả đơn thuốc. Án gồm hai năm cho chất cấm và bốn năm cho can thiệp bằng chứng, thi hành nối tiếp từ ngày 10 tháng 9. **Dữ kiện chính**: - Methylprednisolone là glucocorticoid nhóm S9 của WADA, chỉ bị cấm trong thời gian thi đấu và thuộc loại chất được chỉ định. - Đơn thuốc do một người thân trong gia đình không có đăng ký hành nghề ký, viết trên cuốn sổ kê đơn cũ. - Phòng khám nêu trong đơn xác nhận người ký chưa từng làm việc tại đó; phòng khám thứ hai không tồn tại. - Aga vô địch Tokyo Marathon 2019 và có ba lần về nhì tại các giải World Marathon Majors. - Án phạt kéo đến năm cô 38 tuổi; kết quả giải bán marathon tại Trung Quốc tháng Ba bị hủy cùng tiền thưởng. **Nguồn**: BBC Sport, bài “Ruti Aga: Marathon runner gets six-year ban for fake prescription issued by family member”, dẫn thông cáo của Athletics Integrity Unit ngày 10 tháng 9 | Cross-checked: VuaBong.vn **Hỏi đáp liên quan**: Q: Vì sao án lên tới sáu năm? A: Vì hành vi làm giả bằng chứng là vi phạm độc lập với mức phạt bốn năm, được cộng dồn với hai năm của chất cấm chứ không chạy song song. Q: Methylprednisolone có phải steroid đồng hóa? A: Không, đó là corticosteroid tổng hợp thuộc nhóm S9, chỉ bị cấm trong thời gian thi đấu và được xếp vào loại chất được chỉ định. Q: Aga còn khả năng trở lại thi đấu đỉnh cao không? A: Về lý thuyết cô đủ tuổi trở lại ở 38, nhưng xác suất quay lại đẳng cấp World Marathon Majors rất thấp theo VangBong.vn Player Depth Index.
The prescription was written on an old pad, the kind small clinics still use for handwritten scripts. The person who signed it introduced himself as a doctor and explained that the pad had been left over from a previous workplace. When investigators contacted the clinic named on the prescription, the answer was brief: that person never worked here. The second clinic, the one the prescription was supposedly issued by, does not exist. Three independent answers, one conclusion. That is more or less the entire file, neat to the point of disbelief, and it is precisely that neatness that produced the heaviest sanction in the career of a marathoner who once won Tokyo.
Ruti Aga, 32, from Ethiopia. In 2026 she won the Tokyo Marathon, one of the six largest road races in the world. She has three runner-up finishes at World Marathon Majors events, enough to place her among the elite of women's marathon running in the 2026-2026 window, although the original report does not name the individual races. This March she won a half marathon in China. Her sample there returned a positive for methylprednisolone. She explained it was medication for a knee injury.
The first technical point, and the one most news bulletins get wrong: methylprednisolone is a synthetic glucocorticoid, a corticosteroid, not an anabolic steroid. It sits in Class S9 of the WADA list, prohibited only in competition, and is classified as a Specified Substance, the category regulators acknowledge is more plausibly linked to therapeutic or inadvertent use. Put another way, the doping half of this case sits on the softer side of the rulebook. The baseline sanction for a Specified Substance, absent proof of intent, is two years.

Two years. That was supposed to be the stopping point for a therapeutic misadventure handled correctly. Ruti Aga received six.
Those six years did not come from the substance. They came from the prescription.
The Athletics Integrity Unit, World Athletics' independent integrity body, handled the whole process: testing, results management, prosecution. The structure of the sanction reads clearly enough: two years for the presence of a prohibited substance, plus four years for tampering with evidence, served consecutively rather than concurrently. The WADA Code is explicit that multiple anti-doping rule violations are served one after another. Four plus two makes six, running from 10 September.
What matters is that four is larger than two. The fabrication was punished more heavily than the positive test itself, and that is the central governance lesson of the entire case. Under the anti-doping code, interference with results management is an independent violation with its own penalty, regardless of which substance is involved. An athlete can escape a doping charge with therapeutic evidence; once forged documents enter the file, that door closes.
And the paperwork here was not a sophisticated conspiracy. It was a rough, patched-together attempt by people with no integrity expertise. A family member playing doctor. An old prescription pad. A clinic that does not exist. The AIU's verification matched that crudeness step for step: calling the clinic directly, checking the professional register, confirming the signatory had never been on staff. Three steps, three negative results. Forged documents are now detected so quickly that fabrication has become a way of adding years to your own sentence.
From years of watching road races in Asia, I keep coming back to a detail that rarely gets mentioned: that March half marathon was very likely an appearance-fee race, the kind East African athletes run constantly for the fee. It is part of a road-running economy few people see, where an athlete can race a dozen times a year across a dozen countries with medical and legal support so thin that nobody reads the label closely. The result there is almost certainly annulled, along with the prize money. There are races whose score is never recorded, because people choose to forget.
One thing needs saying to avoid overreach: this case does not constitute evidence of a state doping system. Ethiopia's marathon pipeline is so deep that one individual leaving the roads barely registers competitively. Ruti Aga is a replaceable node. But precisely because that pipeline is deep, it can hide a structural weakness: very few athletes in the system have their own compliance counsel, someone handling medical paperwork, someone to explain that a corticosteroid injection before race day requires a valid therapeutic use exemption. A case like this, with a lawyer from the start, might well have stopped at two years, or less, or nothing at all.
What drew the heavy penalty was not the injection but the absence of a system to catch an athlete when she makes a mistake. I write to recover the names history has edited out of the line-up, and sometimes the name that gets erased is erased by the athlete's own family, with an old prescription pad.
At 32, Aga was at the top of the women's marathon window, where athletes can hold form past 35. The ban runs until she is 38. In theory she is still young enough to return. In practice, six years away from the elite level is close to a full stop: no major invitations, no appearance fees, no sponsorship. Every contract with a woman is a promise postponed indefinitely, and in this case the promise was cancelled outright.
There is a paradox here. With only a corticosteroid positive, the story could have been told as a therapeutic error, a knee injury, an athlete who was not properly advised. Plenty of fans would have sympathised. But the story will be retold, and remembered, as the non-existent clinic and the relative playing doctor. The reputational damage is far larger than the severity of the substance, and no apology repairs it. There are careers that never appear on a transfer list, only in the silence between two touchlines.
So the question left behind is not whether Aga doped. That answer exists, and it is two years. The remaining question is this: in a road-running ecosystem where East African women largely fend for themselves across dozens of races a year, who is responsible for making sure that when her knee hurts, she has a real prescription, and someone genuinely qualified to sign it?
